# Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE

> **NCT07199894** · PHASE3 · RECRUITING · sponsor: **Mansoura University** · enrollment: 120 (estimated)

## Conditions studied

- Nocturnal Enuresis in Children

## Interventions

- **DRUG:** Mirabegron (beta3-adrenoceptor agonist), Anticholinergics
- **DRUG:** Desmopressin (DDAVP)

## Key facts

- **NCT ID:** NCT07199894
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2026-02-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07199894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07199894, "Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07199894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*